Discover
NEUP
Neuphoria Therapeutics Inc.
3.36
1 x 3.89
1 x 3.96
bid
ask
+
0.01
0.30%
1 @ 04:00 PM
3.36 +0.00 (0.00%)
| Ytd | -13.40% | |
| 1y | -82.32% |
3.32
day range
3.41
3.30
52 week range
19.00
| Open | 3.33 | Prev Close | 3.35 | Low | 3.32 | High | 3.41 | Mkt Cap | 18.18M |
| Vol | 2.52K | Avg Vol | 161.66K | EPS | -3.06 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.75 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-17 | 50-d Avg | 3.75 | 200-d Avg | 4.21 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 1.17M | ||
| Revenues (USD) | 811.70K | ||
| Gross Profit | 1.17M | ||
| Operating Expenses | 6.70M | ||
| Research and Development Expense | -419.78K | ||
| Selling, General and Administrative Expense | 1.76M | ||
| Operating Income | -5.53M | ||
| Income Tax Expense | -34.79K | ||
| Net Income | -4.90M | ||
| Net Income Common Stock | -4.90M | ||
| Net Income Common Stock (USD) | -3.39M | ||
| Consolidated Income | -4.90M | ||
| Earnings per Basic Share | -0.95 | ||
| Earnings per Basic Share (USD) | -0.66 | ||
| Earnings per Diluted Share | -0.95 | ||
| Earning Before Interest & Taxes (EBIT) | -4.94M | ||
| Earning Before Interest & Taxes (USD) | -3.41M | ||
| Weighted Average Shares | 4.40M | ||
| Weighted Average Shares Diluted | 4.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.87M | ||
| Cash and Equivalents (USD) | 13.73M | ||
| Trade and Non-Trade Receivables | 813.43K | ||
| Current Assets | 21.07M | ||
| Total Assets | 28.71M | ||
| Current Liabilities | 756.58K | ||
| Total Liabilities | 4.11M | ||
| Accumulated Retained Earnings (Deficit) | -191.80M | ||
| Accumulated Other Comprehensive Income | -2.06M | ||
| Shareholders Equity | 24.60M | ||
| Shareholders Equity (USD) | 17.01M | ||
| Assets Non-Current | 7.64M | ||
| Goodwill and Intangible Assets | 7.64M | ||
| Liabilities Non-Current | 3.35M | ||
| Trade and Non-Trade Payables | 385.58K | ||
| Tax Liabilities | 355.94K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 165.68K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 424.88K | ||
| Net Cash Flow from Operations | 1.21M | ||
| Effect of Exchange Rate Changes on Cash | -788.98K | ||
| Share Based Compensation | 76.34K | ||